Tiagabine: efficacy and safety in partial seizures – current status
Jürgen Bauer, Déirdre Cooper-MahkornDepartment of Epileptology, Bonn University Hospital, GermanyAbstract: Tiagabine hydrochloride (TGB) is a selective gamma-aminobutyric acid (GABA) reuptake inhibitor. TGB is effective as an add-on medication in adults and children 12 ye...
Enregistré dans:
| Auteurs principaux: | Jürgen Bauer, Déirdre Cooper-Mahkorn |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5cfbeb7d45bc4e028fe12bcd568d236a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Lacosamide for the prevention of partial onset seizures in epileptic adults
par: Anna Kelemen, et autres
Publié: (2010) -
An update on the toxicity of Aβ in Alzheimer’s disease
par: Jürgen Götz, et autres
Publié: (2008) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
par: Fabricio González-Andrade, et autres
Publié: (2010) -
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
par: Stéphane Auvin
Publié: (2007) -
Management of refractory complex partial seizures: current state of the art
par: David M Treiman
Publié: (2010)